| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3109/07853899109147924 |
| P698 | PubMed publication ID | 2036198 |
| P2093 | author name string | Mustajoki P | |
| Välimäki M | |||
| Sane T | |||
| P2860 | cites work | Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. | Q51640626 |
| Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal | Q51642223 | ||
| C-Peptide Levels as a Criterion in Treatment of Maturity-Onset Diabetes | Q51645160 | ||
| Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? | Q51671984 | ||
| Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. | Q54346849 | ||
| Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. | Q54383566 | ||
| Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. | Q54423973 | ||
| Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. | Q54431786 | ||
| Insulin Dependence: Problems with the Classification of 100 Consecutive Patients | Q57413122 | ||
| Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans | Q58829532 | ||
| Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver | Q33799804 | ||
| Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes | Q34574702 | ||
| Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes | Q35207824 | ||
| Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas | Q35701941 | ||
| When to use insulin in the maturity onset diabetic | Q36721908 | ||
| Effect of fatty acids on glucose production and utilization in man | Q36992461 | ||
| Type 2 (non-insulin-dependent) diabetes--an epidemiological overview | Q39357787 | ||
| Insulin treatment of non-insulin-dependent diabetes mellitus | Q39532297 | ||
| Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy | Q39563018 | ||
| Role of insulin resistance in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus | Q39578344 | ||
| Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. | Q39648063 | ||
| New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus | Q40144631 | ||
| Infection and diabetes: the case for glucose control | Q40325071 | ||
| Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure | Q41373348 | ||
| Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea | Q42504335 | ||
| Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents | Q42512848 | ||
| One month's insulin treatment of type II diabetes: the early and medium-term effects following insulin withdrawal | Q42521834 | ||
| Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM. | Q43418294 | ||
| A community study of high density lipoproteins in adult noninsulin-dependent diabetics | Q43574640 | ||
| Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide | Q44215853 | ||
| Treatment of patients with non-insulin-dependent diabetes mellitus: diabetic control and insulin secretion and action after different treatment modalities | Q44349059 | ||
| Changes in High Density Lipoprotein Cholesterol after Initiation of Insulin Therapy in Non-Insulin Dependent Diabetes Mellitus: Relationship to Changes in Body Weight | Q47254796 | ||
| Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects. | Q51619103 | ||
| A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy. | Q51620175 | ||
| Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. | Q51621111 | ||
| Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents. | Q51623851 | ||
| Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. | Q51625554 | ||
| [Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial] | Q51625915 | ||
| Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. | Q51626419 | ||
| Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. | Q51627070 | ||
| Effect of insulin therapy on lipoproteins in non-insulin dependent diabetes mellitus (NIDDM). | Q51628413 | ||
| Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement. | Q51628832 | ||
| Reversal of severe diabetic hyperlipidemia by prandial insulinization. | Q51631307 | ||
| Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus. | Q51634559 | ||
| Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. | Q51634813 | ||
| The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. | Q51639006 | ||
| New tactics for type 2 diabetes: regimens based on intermediate-acting insulin taken at bedtime. | Q51639359 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Insulin Therapy | Q2002370 |
| P304 | page(s) | 13-19 | |
| P577 | publication date | 1991-02-01 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Insulin therapy in maturity-onset diabetes | |
| P478 | volume | 23 |
| Q51550685 | Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus. |
| Q43734824 | Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes |
| Q36240017 | Management of the Adult Onset Diabetic with Sulfonylurea Drug Failure |
| Q67472582 | Morning or bed-time insulin with or without glibenclamide in elderly Type 2 diabetic patients unresponsive to oral antidiabetic agents |
| Q40696805 | Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review |
Search more.